Literature DB >> 29986213

Structure-kinetic relationships that control the residence time of drug-target complexes: insights from molecular structure and dynamics.

Hao Lu1, James N Iuliano2, Peter J Tonge3.   

Abstract

Time-dependent target occupancy is a function of both the thermodynamics and kinetics of drug-target interactions. However, while the optimization of thermodynamic affinity through approaches such as structure-based drug design is now relatively straight forward, less is understood about the molecular interactions that control the kinetics of drug complex formation and breakdown since this depends on both the ground and transition state energies on the binding reaction coordinate. In this opinion we highlight several recent examples that shed light on current approaches that are elucidating the factors that control the life-time of the drug-target complex.
Copyright © 2018 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29986213      PMCID: PMC6066427          DOI: 10.1016/j.cbpa.2018.06.002

Source DB:  PubMed          Journal:  Curr Opin Chem Biol        ISSN: 1367-5931            Impact factor:   8.822


  58 in total

1.  Molecular basis for the long duration of action and kinetic selectivity of tiotropium for the muscarinic M3 receptor.

Authors:  Christofer S Tautermann; Tobias Kiechle; Daniel Seeliger; Sonja Diehl; Eva Wex; Rolf Banholzer; Florian Gantner; Michael P Pieper; Paola Casarosa
Journal:  J Med Chem       Date:  2013-10-25       Impact factor: 7.446

Review 2.  The behavior and significance of slow-binding enzyme inhibitors.

Authors:  J F Morrison; C T Walsh
Journal:  Adv Enzymol Relat Areas Mol Biol       Date:  1988

3.  Design, Synthesis, and Biological Evaluation of Novel Type I1/2 p38α MAP Kinase Inhibitors with Excellent Selectivity, High Potency, and Prolonged Target Residence Time by Interfering with the R-Spine.

Authors:  Niklas M Walter; Heike K Wentsch; Mike Bührmann; Silke M Bauer; Eva Döring; Svenja Mayer-Wrangowski; Adrian Sievers-Engler; Nicole Willemsen-Seegers; Guido Zaman; Rogier Buijsman; Michael Lämmerhofer; Daniel Rauh; Stefan A Laufer
Journal:  J Med Chem       Date:  2017-09-07       Impact factor: 7.446

Review 4.  Drug discovery for a new generation of covalent drugs.

Authors:  Amit S Kalgutkar; Deepak K Dalvie
Journal:  Expert Opin Drug Discov       Date:  2012-05-19       Impact factor: 6.098

5.  Ligand entry and exit pathways in the beta2-adrenergic receptor.

Authors:  Ting Wang; Yong Duan
Journal:  J Mol Biol       Date:  2009-08-06       Impact factor: 5.469

6.  The terminal (catalytic) adenosine of the HIV LTR controls the kinetics of binding and dissociation of HIV integrase strand transfer inhibitors.

Authors:  David R Langley; Himadri K Samanta; Zeyu Lin; Michael A Walker; Mark R Krystal; Ira B Dicker
Journal:  Biochemistry       Date:  2008-12-23       Impact factor: 3.162

7.  KLIFS: a structural kinase-ligand interaction database.

Authors:  Albert J Kooistra; Georgi K Kanev; Oscar P J van Linden; Rob Leurs; Iwan J P de Esch; Chris de Graaf
Journal:  Nucleic Acids Res       Date:  2015-10-22       Impact factor: 16.971

8.  The ligand binding mechanism to purine nucleoside phosphorylase elucidated via molecular dynamics and machine learning.

Authors:  Sergio Decherchi; Anna Berteotti; Giovanni Bottegoni; Walter Rocchia; Andrea Cavalli
Journal:  Nat Commun       Date:  2015-01-27       Impact factor: 14.919

9.  Drug-Target Kinetics in Drug Discovery.

Authors:  Peter J Tonge
Journal:  ACS Chem Neurosci       Date:  2017-07-14       Impact factor: 4.418

10.  Targeted inhibition of mutant IDH2 in leukemia cells induces cellular differentiation.

Authors:  Fang Wang; Jeremy Travins; Byron DeLaBarre; Virginie Penard-Lacronique; Stefanie Schalm; Erica Hansen; Kimberly Straley; Andrew Kernytsky; Wei Liu; Camelia Gliser; Hua Yang; Stefan Gross; Erin Artin; Veronique Saada; Elena Mylonas; Cyril Quivoron; Janeta Popovici-Muller; Jeffrey O Saunders; Francesco G Salituro; Shunqi Yan; Stuart Murray; Wentao Wei; Yi Gao; Lenny Dang; Marion Dorsch; Sam Agresta; David P Schenkein; Scott A Biller; Shinsan M Su; Stephane de Botton; Katharine E Yen
Journal:  Science       Date:  2013-04-04       Impact factor: 63.714

View more
  6 in total

Review 1.  Pharmacokinetic-pharmacodynamic models that incorporate drug-target binding kinetics.

Authors:  Fereidoon Daryaee; Peter J Tonge
Journal:  Curr Opin Chem Biol       Date:  2019-04-28       Impact factor: 8.822

2.  A structure-kinetic relationship study using matched molecular pair analysis.

Authors:  Doris A Schuetz; Lars Richter; Riccardo Martini; Gerhard F Ecker
Journal:  RSC Med Chem       Date:  2020-09-21

3.  Kinetic Heterogeneity of Cancer Cell Fractional Killing.

Authors:  Zintis Inde; Giovanni C Forcina; Kyle Denton; Scott J Dixon
Journal:  Cell Rep       Date:  2020-07-07       Impact factor: 9.423

4.  Determination of Multidirectional Pathways for Ligand Release from the Receptor: A New Approach Based on Differential Evolution.

Authors:  Hoang Linh Nguyen; Nguyen Quoc Thai; Mai Suan Li
Journal:  J Chem Theory Comput       Date:  2022-05-05       Impact factor: 6.578

5.  Utilizing the Combination of Binding Kinetics and Micro-Pharmacokinetics Link in Vitro α-Glucosidase Inhibition to in Vivo Target Occupancy.

Authors:  Guopeng Wang; Yanhua Ji; Xueyan Li; Qian Wang; Hang Gong; Baoshun Wang; Yang Liu; Yanli Pan
Journal:  Biomolecules       Date:  2019-09-16

6.  Ritonavir and xk263 Binding-Unbinding with HIV-1 Protease: Pathways, Energy and Comparison.

Authors:  Jianan Sun; Mark Anthony V Raymundo; Chia-En A Chang
Journal:  Life (Basel)       Date:  2022-01-13
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.